RAC 1.63% $1.81 race oncology ltd

RAC media coverage, page-720

  1. 2,651 Posts.
    lightbulb Created with Sketch. 3246
    Considering the recent discoveries; it would be a lot easier for a small company like RAC to commercialise an Anthracyclene/Decitabine/PD1 synergiser than a stand alone salvage chemotherapeutic or FTO inhibitor.

    I still think we're gone shortly after any positive readouts in the EM AML/MDS trial (registered as a liquid tumour agent/Decitabine synergiser - not just one cancer indication).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.81
Change
-0.030(1.63%)
Mkt cap ! $308.2M
Open High Low Value Volume
$1.88 $1.89 $1.80 $88.27K 48.66K

Buyers (Bids)

No. Vol. Price($)
1 80 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.82 4500 1
View Market Depth
Last trade - 10.46am 24/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.